Jun 2022 Articles

Articles
Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials
Schludi B, Giugliano RP, Sabatine MS, et al.
Journal:
J Clin Lipidol

First published: June 6, 2022 DOI: 10.1016/j.jacl.2022.05.069
View
- Share
Articles
Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT
Gaba P, Bhatt DL, Mason RP, et al.
Journal:
J Clin Lipidol

First published: June 4, 2022 DOI: 10.1016/j.jacl.2022.05.067
View
- Share
Articles
Association between REDUCE-IT criteria, coronary artery disease severity and cardiovascular events: The Western Denmark Heart Registry
Mortensen MB, Dzaye O, Razavi AC, et al.
Journal:
Eur J Prev Cardiol

First published: June 3, 2022 DOI: 10.1093/eurjpc/zwac104
View
- Share

1 2